Variant report
Variant | esv1963446 |
---|---|
Chromosome Location | chr7:38580697-38581133 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs191134169 | chr7:38580697-38580698 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs12155369 | chr7:38580704-38580705 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs569193881 | chr7:38580726-38580727 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs368765374 | chr7:38580769-38580770 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs113519991 | chr7:38580796-38580797 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs144543093 | chr7:38580824-38580825 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs55660201 | chr7:38580832-38580833 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs527575056 | chr7:38580860-38580861 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs553733190 | chr7:38580862-38580863 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs183357861 | chr7:38580863-38580864 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs188050805 | chr7:38580885-38580886 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs374726557 | chr7:38580888-38580889 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs372772703 | chr7:38580889-38580890 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs3839745 | chr7:38580890-38580891 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs78443763 | chr7:38580928-38580929 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs536060013 | chr7:38580980-38580981 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs191983942 | chr7:38580984-38580985 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs146603987 | chr7:38581044-38581045 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs76309521 | chr7:38581048-38581049 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs546728419 | chr7:38581056-38581057 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs549344159 | chr7:38581105-38581106 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Williams-beuren syndrome | 22470819 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Breast cancer | 21364760 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Prostate cancer | 18632612 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Gastric cancer | 24379144 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:38564200-38580800 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
2 | chr7:38579400-38586800 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr7:38580200-38581200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
4 | chr7:38580600-38581800 | Enhancers | Fetal Heart | heart |
5 | chr7:38580600-38583800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr7:38580600-38583800 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
7 | chr7:38580800-38581400 | Enhancers | Sigmoid Colon | Sigmoid Colon |
8 | chr7:38580800-38581800 | Enhancers | Left Ventricle | heart |
9 | chr7:38580800-38582200 | Enhancers | Pancreatic Islets | Pancreatic Islet |
10 | chr7:38581000-38581600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
11 | chr7:38581000-38581800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |